Abstract
Economic appraisal seeks to provide policy-makers with guidance about how scarce resources can be used to derive the greatest possible social benefit. Its use in the health sector has increased dramatically over the last decade although much of it has been focused on the problems of the more developed countries. The relatively sparse literature on communicable diseases has been dominated by interventions related to HIV/AIDS, hepatitis, malaria and tropical diseases. Reviews of this literature from the perspective of specific conditions such as Hepatitis B are already available, and recently the entire literature has been evaluated against the technical criteria for economic evaluations published in standard textbooks. Accordingly, this paper focuses on issues which would make economic appraisal more useful to policy-makers than it currently is. Given that few countries have the resources to undertake all the necessary analysis in their own settings, it is important that studies in one setting are undertaken in a way that allow generalisability to similar settings. Some of the most important challenges this poses for cost-effectiveness analysis (CEA) are identified. Firstly, incremental analysis is appropriate to local decision ...Continue Reading
References
Feb 22, 1992·Proceedings. Biological Sciences·C NokesD A Bundy
Aug 1, 1994·Social Science & Medicine·L Brenzel, P Claquin
Jul 1, 1993·Social Science & Medicine·M DrummondJ Mason
Mar 1, 1993·Transactions of the Royal Society of Tropical Medicine and Hygiene·C Nokes, D A Bundy
Mar 1, 1996·Health Economics·T JeffersonV Demicheli
Oct 1, 1996·Journal of Biosocial Science·C Nokes
Apr 15, 1997·Acta Tropica·J M Kirigia
May 21, 1997·JAMA : the Journal of the American Medical Association·M F DrummondD Heyland
Jan 15, 1998·Lancet·L GilsonR Hayes
May 5, 1998·Medical Decision Making : an International Journal of the Society for Medical Decision Making·M Johannesson, B J O'Brien
Jun 5, 1998·Annual Review of Public Health·J D GrahamM C Weinstein
Nov 11, 1998·Health Economics·J M Kirigia
Jan 9, 1991·Health Policy·M Johannesson, B Jönsson
Dec 10, 1990·Journal of Health Economics·M JohannessonL Borgquist
Apr 1, 1994·The International Journal of Health Planning and Management·E de JongheK Styblo
May 1, 1999·Tropical Medicine & International Health : TM & IH·P G ColemanA Mills
Sep 15, 1999·Clinical Therapeutics·K Blumenschein, M Johannesson
Jan 6, 2000·PharmacoEconomics·S BirchB O'Brien
May 2, 2000·Health Policy and Planning·C A Goodman, A J Mills
May 3, 2000·Health Economics·C J MurrayR M Baltussen
Oct 24, 2000·Tropical Medicine & International Health : TM & IH·P Van der Stuyft, J P Unger
Jan 4, 2001·Health Economics·D Walker, J A Fox-Rushby
Citations
Mar 7, 2003·Lancet·Christopher J L MurrayDavid B Evans
Sep 14, 2001·Tropical Medicine & International Health : TM & IH·J UtzingerB H Singer
Oct 12, 2010·PloS One·Zana C SomdaMartin I Meltzer
Apr 21, 2011·PharmacoEconomics·Mark Jit, Marc Brisson
Mar 26, 2004·Tropical Medicine & International Health : TM & IH·Wim Van Damme, Wim Van Lerberghe
Jan 2, 2007·Cost Effectiveness and Resource Allocation : C/E·Sripen Tantivess, Gill Walt
Jun 1, 2006·Journal of Empirical Research on Human Research Ethics : JERHRE·John E SidleEric M Meslin
Feb 7, 2018·Health Research Policy and Systems·Alia LuzYot Teerawattananon
Jun 22, 2002·Drugs·François Nosten, Philippe Brasseur
Mar 14, 2012·PharmacoEconomics·Nadia DemarteauBaudouin Standaert
Feb 5, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Mark Bigham, Ray Copes